Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group)

Epidermal growth factor receptor 1 (EGFR-1) overexpression is usually described as linked with a worse prognosis in a variety of tumours of epithelial origin. However, its role in ovarian cancer is still controversial. The aim of the present study was to analyse the prognostic impact of EGFR-1 in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Elie, C, Geay, J F, Morcos, M, Le Tourneau, A, Girre, V, Broët, P, Marmey, B, Chauvenet, L, Audouin, J, Pujade-Lauraine, E, Camilleri-Broët, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409858/
https://www.ncbi.nlm.nih.gov/pubmed/15226774
http://dx.doi.org/10.1038/sj.bjc.6601961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409858/
https://www.ncbi.nlm.nih.gov/pubmed/15226774
http://dx.doi.org/10.1038/sj.bjc.6601961

Ejemplares similares